Country Club Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,535
Closed -$208K 291
2022
Q4
$208K Buy
+1,535
New +$193K 0.02% 276
2022
Q3
Sell
-1,598
Closed -$215K 266
2022
Q2
$215K Hold
1,598
0.02% 252
2022
Q1
$215K Buy
+1,598
New +$192K 0.02% 255

Other funds holding AZN

Country Club Bank's AZN Position: Q1 2023 in Review

Country Club Bank sold out of AstraZeneca (AZN) in Q1 2023, closing a stake of 1,535 shares — an estimated $208K sold.

Country Club Bank first reported a position in AZN in Q1 2022 and held it in 3 quarters. The position peaked at $215K in Q2 2022. 1,056 funds tracked by Wall St. Rank hold AZN as of Q1 2023.

  • Country Club Bank reported no remaining AstraZeneca position as of Q1 2023 after selling out during the quarter.
  • Country Club Bank sold 1,535 AstraZeneca shares in Q1 2023, an estimated $208K.
  • Country Club Bank first reported a position in AstraZeneca in Q1 2022 and held it in 3 quarters.
  • Country Club Bank's AstraZeneca position peaked at $215K in Q2 2022.
  • 1,056 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2023.

Based on Country Club Bank's 13F filing for Q1 2023, filed 12 Apr 2023.